Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Indigenous Bloom Hemp Corp VRTHF

Indigenous Bloom Hemp Corporation is a Canada-based company, which produce and sell hemp extracts. The Company operates a large scale industrial hemp farm in southern Manitoba on approximately 200 acres of zoned farmland. The primary business of the Company is the sale of hemp biomass and flower (Hemp), Phyto cannabinoid rich (PCR) extracts derived from hemp biomass (Hemp Extracts). The Company is in the process of developing, through acquisition and construction, Hemp Products for general consumer end-use. It has two primary products which it plans to sell and is in the process of expanding its product line. The Company’s primary product to date is Hemp Biomass, which is sold pre-processed to customers and partners who process the biomass into Hemp Extracts. The Company has cultivated approximately 100,000 kilograms of Hemp Biomass.


GREY:VRTHF - Post by User

Bullboard Posts
Comment by EdmundHon Sep 14, 2018 6:27pm
55 Views
Post# 28624268

RE:RE:RE:RE:WTF?

RE:RE:RE:RE:WTF?I don't know why, but it didn't look like that licence was ever going to be approved for that facility. It was first sent in 2014, and had been in the final review stage for a full year - I would guess some members of the company didn't pass the screening. But could have been anything.

My investment in Veritas is based on the IP and the science behind their strains. 

Sucks if you got burnt, investing on the hope of SOM receiving it's license. They did give it prominence in the PDF investor presentation which is not cool, but also down played it in their last corporate update.

I think patience will pay off on this one... keep your eye open for news on the clinical trail of CTL-X - that is the key.
Bullboard Posts
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse